ijms-logo

Journal Browser

Journal Browser

Axonopathy in Neurodegenerative Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 23623

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain
Interests: neurodegeneration; C elegans; lipid droplets; cell death; cell biology

Special Issue Information

Dear Colleagues, 

Axonal degeneration or axonopathy is a neurotoxic disorder in which the primary site of toxicity is the axon. Axonopathies involve alterations in the cytoskeleton and defects in axonal transport and represent a common starting point for neuronal pathological alterations across a very wide range of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease. However, the molecular pathways that regulate this process are unknown.

Neurons have highly specialized structures for intercellular communication. In particular, axons transfer proteins and organelles over considerable distances throughout the nervous system. Furthermore, the constant quality of proteins and mitochondria is critical for correct neuronal function. Consequently, axonal transport is necessary to maintain neuronal homeostasis, which particularly depends on efficient degradation pathways such as the autophagy mechanism. As such, the precise investigation of autophagy in the soma, axons, or synapses would represent a beneficial therapeutic intervention to combat neurodegenerative diseases. Importantly, the pathological contribution of an over-activation of autophagy should also be monitored very carefully.

Lipids and lipid-metabolizing enzymes control fundamental aspects of the autophagy process, and lipids themselves have also been identified as autophagy substrates. In the process referred to as macrolipophagy, cellular fat such as triacylglycerides (TAG) is directly consumed (or broken down into fatty acids) in the form of lipid droplets (LDs) by autophagolysosomes for the purpose of energy homeostasis. In addition, cholesterol has been implicated in the organization of microdomains within lysosomal membranes that control the efficacy of chaperone-mediated autophagy as well as autophagosome–lysosome fusion.

LDs are cytoplasmic organelles that store neutral lipids for membrane synthesis and energy. In addition to energy storage, LDs play other important functions, including sequestration of toxic proteins, protection from lipotoxicity, and provision of precursors for membrane biosynthesis, hormones, and lipoproteins. Notably, neurodegenerative diseases share lipid dysregulation as a metabolic feature in disease pathology.Hence, the knowledge of the convergent molecular mechanisms between axonal maintenance, autophagy, and lipid droplets is critical to combat neurodegenerative diseases. This Special Issue will collect papers focused on understanding the mechanisms relating autophagy to axonal damage in axonopathies in the context of lipid metabolism.

Dr. Esther Dalfó
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Axonopathy
  • Autophagy
  • Lipid metabolism
  • Lipid droplets
  • Neurodegeneration

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1131 KiB  
Review
Prion Protein: The Molecule of Many Forms and Faces
by Valerija Kovač and Vladka Čurin Šerbec
Int. J. Mol. Sci. 2022, 23(3), 1232; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23031232 - 22 Jan 2022
Cited by 12 | Viewed by 4178
Abstract
Cellular prion protein (PrPC) is a glycosylphosphatidylinositol (GPI)-anchored protein most abundantly found in the outer membrane of neurons. Due to structural characteristics (a flexible tail and structured core), PrPC interacts with a wide range of partners. Although PrPC has [...] Read more.
Cellular prion protein (PrPC) is a glycosylphosphatidylinositol (GPI)-anchored protein most abundantly found in the outer membrane of neurons. Due to structural characteristics (a flexible tail and structured core), PrPC interacts with a wide range of partners. Although PrPC has been proposed to be involved in many physiological functions, only peripheral nerve myelination homeostasis has been confirmed as a bona fide function thus far. PrPC misfolding causes prion diseases and PrPC has been shown to mediate β-rich oligomer-induced neurotoxicity in Alzheimer’s and Parkinson’s disease as well as neuroprotection in ischemia. Upon proteolytic cleavage, PrPC is transformed into released and attached forms of PrP that can, depending on the contained structural characteristics of PrPC, display protective or toxic properties. In this review, we will outline prion protein and prion protein fragment properties as well as overview their involvement with interacting partners and signal pathways in myelination, neuroprotection and neurodegenerative diseases. Full article
(This article belongs to the Special Issue Axonopathy in Neurodegenerative Diseases)
Show Figures

Figure 1

18 pages, 2514 KiB  
Review
Cofilin Signaling in the CNS Physiology and Neurodegeneration
by Jannatun Nayem Namme, Asim Kumar Bepari and Hirohide Takebayashi
Int. J. Mol. Sci. 2021, 22(19), 10727; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms221910727 - 03 Oct 2021
Cited by 23 | Viewed by 7325
Abstract
All eukaryotic cells are composed of the cytoskeleton, which plays crucial roles in coordinating diverse cellular functions such as cell division, morphology, migration, macromolecular stabilization, and protein trafficking. The cytoskeleton consists of microtubules, intermediate filaments, and actin filaments. Cofilin, an actin-depolymerizing protein, is [...] Read more.
All eukaryotic cells are composed of the cytoskeleton, which plays crucial roles in coordinating diverse cellular functions such as cell division, morphology, migration, macromolecular stabilization, and protein trafficking. The cytoskeleton consists of microtubules, intermediate filaments, and actin filaments. Cofilin, an actin-depolymerizing protein, is indispensable for regulating actin dynamics in the central nervous system (CNS) development and function. Cofilin activities are spatiotemporally orchestrated by numerous extra- and intra-cellular factors. Phosphorylation at Ser-3 by kinases attenuate cofilin’s actin-binding activity. In contrast, dephosphorylation at Ser-3 enhances cofilin-induced actin depolymerization. Cofilin functions are also modulated by various binding partners or reactive oxygen species. Although the mechanism of cofilin-mediated actin dynamics has been known for decades, recent research works are unveiling the profound impacts of cofilin dysregulation in neurodegenerative pathophysiology. For instance, oxidative stress-induced increase in cofilin dephosphorylation is linked to the accumulation of tau tangles and amyloid-beta plaques in Alzheimer’s disease. In Parkinson’s disease, cofilin activation by silencing its upstream kinases increases α-synuclein-fibril entry into the cell. This review describes the molecular mechanism of cofilin-mediated actin dynamics and provides an overview of cofilin’s importance in CNS physiology and pathophysiology. Full article
(This article belongs to the Special Issue Axonopathy in Neurodegenerative Diseases)
Show Figures

Figure 1

22 pages, 6648 KiB  
Review
Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
by Rongrong Han, Jing Liang and Bing Zhou
Int. J. Mol. Sci. 2021, 22(11), 5887; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115887 - 31 May 2021
Cited by 45 | Viewed by 11282
Abstract
Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably [...] Read more.
Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal functioning of neurons, which is widely observed in neurodegenerative disease. Understanding the mechanisms of metabolic adaptation during disease progression has become a major focus of research, and interventions in these processes may relieve the neurons from degenerative stress. In this review, we highlight evidence of mitochondrial dysfunction, decreased glucose uptake, and diminished glucose metabolism in different neurodegeneration models such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). We also discuss how hypoxia, a metabolic reprogramming strategy linked to glucose metabolism in tumor cells and normal brain cells, and summarize the evidence for hypoxia as a putative therapy for general neurodegenerative disease. Full article
(This article belongs to the Special Issue Axonopathy in Neurodegenerative Diseases)
Show Figures

Figure 1

Back to TopTop